T-cell monitoring and immunotherapy for treating graft-versus-host disease

Effie W Petersdorf

Genetic Mechanisms of Survivorship Disparities after Unrelated HCT

Leukaemia

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Talya Salz

Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Non-Hodgkin lymphoma Hodgkin lymphoma

Pier Paolo Pandolfi

Targeting Tumor Suppressive Pathways for Cancer Therapy

Leukaemia

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Wing Leung

KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN

Leukaemia

Pediatric oncology or childhood cancer

Emily Smith Tonorezos

Exercise and QUality diet After Leukemia

Leukaemia

Pediatric oncology or childhood cancer

Aude Chapuis

Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W

Leukaemia

Melinda Sue Butschkovacic

Fanconi Anemia as a Model for Susceptibility to Human Papillomavirus Infection

Non-Hodgkin lymphoma Hodgkin lymphoma